SHATHA ALKATIB: Open Payments
NPI 1376948919 · WESTLAND, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$980 in 13 payments from 7 companies in 2025. Trend: 2023 $1,398 · 2024 $900 · 2025 $980
Food & beverage: $980
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $355 |
| Alkermes, Inc. | 3 | $180 |
| Otsuka America Pharmaceutical, Inc. | 3 | $171 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Axsome Therapeutics, Inc. | 1 | $111 |
| ABBVIE INC. | 1 | $26 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
Products named: UZEDY, REXULTI, LYBALVI, AUSTEDO XR, COBENFY, Auvelity, ARISTADA, VRAYLAR.
Industry payments across MI — which companies pay providers there.
